dr. A. Alipour
Specialisme
Cardioloog-elektrofysioloog
Functie
Cardioloog-elektrofysioloog
Biografie
Werkervaring
Sinds 1 januari 2015 ben ik cardioloog. Opleiding tot cardioloog-elektrofysioloog rondde ik af op 31 december 2016 in het st Antonius Ziekenhuis. Vanaf 1 januari 2017 werkzaam in het ziekenhuis Rivierenland te Tiel en per 1 juli 2024 treed ik toe tot vakgroep cardiologie in het Amphia!
Opleiding
- 1998-2005 opleiding Geneeskunde, Universiteit Utrecht
- 2005-2009 Promotie-onderzoek; ‘Leukocytes and Complement in Atherosclerosis’. Gepromoveerd op 9-2-2012 aan de Universiteit Leiden.
- 2009-2015 Opleiding Cardiologie, St. Antonius Ziekenhuis Nieuwegein
- 2015-2016 Fellowship elektrofysiologie, St. Antonius Ziekenhuis Nieuwegein
- EHRA examen elektrofysiologie level 1+2 behaald
- EHRA device examen level 1+2 behaald
Publicaties
- ‘2-year outcomes of phased radiofrequency ablation for atrial fibrillation with the second-generation PVAC Gold ablation catheter.’
Klaver MN, Wintgens LIS, Wijffels MCEF, van Dijk VF, Alipour A, Chaldoupi SM, Derksen R, Peper J, Balt JC, Boersma LVA.
J Interv Card Electrophysiol. 2022; 65:471-480. - ‘Acute success and safety of the second-generation PVAC GOLD phased RF ablation catheter for atrial fibrillation’.
Klaver MN, Wintgens LIS, Wijffels MCEF, Balt JC, van Dijk VF, Alipour A, Chaldoupi SM, Derksen R, Boersma LVA.
J Interv Card Electrophysiol. 2021;60:261-270. - ‘Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.’
Wintgens LIS, Klaver MN, Swaans MJ, Alipour A, Balt JC, van Dijk VF, Rensing BJWM, Wijffels MCEF, Boersma LVA.
Europace. 2019;21:428-433. - ‘Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands.’
van den Brink FS, Swaans MJ, Hoogendijk MG, Alipour A, Kelder JC, Jaarsma W, Eefting FD, Groenmeijer B, Kupper AJF, Ten Berg JM.
Eur Heart J Qual Care Clin Outcomes. 2017;3:141-147. - ‘Feasibility of multiplane microtransoesophageal echocardiographic guidance in structural heart disease transcatheter interventions in adults.’
Nijenhuis VJ, Alipour A, Wunderlich NC, Rensing BJWM, Gijsbers G, Ten Berg JM, Suttorp MJ, Boersma LVA, van der Heyden JAS, Swaans MJ.
Neth Heart J. 2017;25:669-674. - ‘Glucose-dependent leucocyte activation in familial hypercholesterolemia.’
Koks N, de Vries MA, Birnie E, Alipour A, Castro Cabezas M.
Eur J Clin Invest. 2017;47:839-846. - ‘Novel stroke risk reduction in atrial fibrillation: the Watchman left atrial appendage closure’.
lipour A, Swaans MJ, Wintgens LI, Balt JC, Rensing BJWM, Boersma LVA.
Journal of Vascular Health and Risk Management. 2017;13:81-90. - ‘Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility.’
Swaans MJ, Wintgens LI, Alipour A, Rensing BJ, Boersma LV.
Med Devices. 2016;9:309-16. - ‘Differential leucocyte RNA expression in the coronary arteries compared to systemic circulation discriminates between patients with and those without coronary artery disease.’
Ribalta J, Alipour A, Sánchez-Cabo F, Vallvé JC, Njo T, Álvarez R, Janssen H, Liem A, Dopazo A, Castro-Cabezas M.
Clin Investig Arterioscler. 2017;29:60-66. - ‘Coronary leukocyte activation in relation to progression of coronary artery disease.’
de Vries MA, Alipour A, Birnie E, Westzaan A, van Santen S, van der Zwan E, Liem AH, van der Meulen N, Castro Cabezas M.
Front Med. 2016;10:85-90. - ‘Ablation for Atrial Fibrillation Combined With Left Atrial Appendage Closure.’
Alipour A, Swaans MJ, van Dijk VF, Balt JC, Post MC, Bosschaert MAR, Rensing BJ, Reddy VY, Boersma LVA.
JACC EP. 2015;1:486-495. - ‘In vivo evidence for chylomicrons as mediators of postprandial inflammation.’
de Vries MA, Klop B, Alipour A, van de Geijn GJ, Prinzen L, Liem AH, Valdivielso P, Rioja Villodres J, Ramírez-Bollero J, Castro Cabezas M.
Atherosclerosis. 2015;243:540-5. - ‘Unintentional sealing of the mitral valve with a second MitraClip. "Once bitten, twice shy".’
Alipour A, Swaans MJ, Post MC, Rensing BJ, Eefting FD, Van der Heyden JA.
EuroIntervention. 2015;11:597. - ‘Using the Watchman device to close the left atrial appendage reduces risk of stroke in atrial fibrillation, compared to using warfarin.’
Swaans MJ, Alipour A, Boersma LV.
Evid Based Med. 2015;20:101. - ‘Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls.’
de Vries MA, Alipour A, Klop B, van de Geijn GJ, Janssen HW, Njo TL, van der Meulen N, Rietveld AP, Liem AH, Westerman EM, de Herder WW, Castro Cabezas M.
Metabolism. 2015;64:213-7 - ‘Survival of transcatheter mitral valve repair compared to surgical and conservative treatment in high risk patients.’
Swaans MJ, Bakker ALM, Alipour A, Post MC, Kelder JC, de Kroon TL, Eefting FD, Rensing BWJM, Van der Heyden JAS. JACC Cardiovasc
Interv. 2014;7:875-81. - ‘Trans-vessel Gradient of Myeloperoxidase in Coronary Artery Disease.’
Alipour A, Ribalta J, Njo TL, Janssen JW, Birnie E, van Miltenburg AJM, Elte JWF, Castro Cabezas M.
Eur J Clin Invest. 2013;43:920-5. - ‘Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.’
Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV. J Vis Exp.
2013;26;(72):e3818. - ‘Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.’
Alipour A, Valdivielso P, Elte JW, Janssen HW, Rioja J, van der Meulen N, van Mechelen R, Njo TL, González-Santos P, Rietveld AP, Castro Cabezas M.
Eur J Clin Invest. 2012;42:702-8. - ‘Erythrocyte-associated apolipoprotein B and its relationship with clinical and subclinical atherosclerosis.’
Bovenberg SA, Klop B, Alipour A, Martinez-Hervas S, Westzaan A, van de Geijn GJ, Janssen HW, Njo T, Birnie E, van Mechelen R, Rietveld AP, Elte JW, Castro Cabezas M.
Eur J Clin Invest 2012;42:365-70. - ‘Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin’.
Alipour A, Castro Cabezas M, Elte JWF, Vallvé JC, Ribalta J, Zwinderman AH, Defesche JC, Jukema JW.
Atherosclerosis 2011;215:125-9. - ‘ApoB48 as a Marker of Atherosclerosis in Patients with Familial Lipid Disorders,Type 2 Diabetes Mellitus and Coronary Artery Disease’.
Alipour A, Valdivielso P, Elte JWF, Janssen JW, Rioja J, Njo TL, González-Santos P, Rietveld AP, Castro Cabezas M.
Circulation supp. 2010;122:A19159. - ‘Cell-mediated lipoprotein transport: A novel anti-atherogenic concept’.
Bovenberg SA, Alipour A, Elte JW, Rietveld AP, Janssen JW, van de Geijn GJ, Njo TN, van Mechelen R, Hervas SM, Cabezas MC.
Atheroscler Suppl. 2010;11:25-29. - ‘Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects’.
Alipour A, van Oostrom AJ, Van Wijk JP, Verseyden C, Plokker HW, Jukema JW, Rabelink AJ, Castro Cabezas M.
Atherosclerosis 2009 206:444-450. - ‘Comparison of different methods to investigate postprandial lipaemia’.
van Oostrom AJ, Alipour A, Sijmonsma TP, Verseyden C, Dallinga-Thie GM, Plokker HW, Castro Cabezas M.
Neth J Med 2009;67:13-20. - ‘Novel aspects of postprandial lipemia in relation to atherosclerosis’.
Alipour A, Elte JWF, van Zaanen HCT, Rietveld AP, Castro Cabezas M.
Atheroscler supp 2008;9:39-44. - ‘Leukocyte activation by triglyceride-rich lipoproteins’.
Alipour A, van Oostrom AJHHM, Izraeljan A, Collins J, Frayn KN, Elte JWF, Castro Cabezas M. Arterioscler Thromb
Vasc Biol 2008;28:792-797. - ‘Postprandial inflammation and endothelial dysfunction’.
Alipour A, Elte JWF, van Zaanen HCT, Rietveld AP, Castro Cabezas M.
Biochem Soc Trans. 2007;35(Pt 3):466-469. - ‘The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers’.
van Oostrom AJHHM, Alipour A, Plokker HWM, Sniderman AD, Castro Cabezas M.
Atherosclerosis 2007;190:167-173. - ‘Deficiency of mannose binding lectin is associated to impaired metabolism of VLDL1 particles despite normal fasting plasma triglycerides’.
Alipour A, van Oostrom AJHHM, Van Wijk JPH, Verseyden C, Plokker HWM, Jukema JW, Rabelink AJ, Castro Cabezas M.
Circulation suppl 2007;1098
Lidmaatschappen
- Nederlandse vereniging voor cardiologie (NVVC)
- Nederlandse Hart Ritme Associatie (NHRA)
- European Society of Cardiology (ESC)
- European Heart Rhythm Association (EHRA)
BIG nummer
99064621801